Former Chief Executive Officer · Teladoc Health, Inc. (TDOC)

Jason Gorevic

A named executive officer of Teladoc Health in every fiscal year CompBrief holds from FY2016 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$9,366,276

Salary $211,318Stock awards $5,943,704

FY2023: $11,613,736

2nd of 8 named executive officers at Teladoc Health by FY2024 total.

8 named officers on file for Teladoc Health, FY2024

Jason Gorevic’s pay file — $29

  • 9 fiscal years of pay, line by line
  • 13 equity grants, each cited to its filing
  • TDOC’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Teladoc Health’s whole pay program stands against its peers

  • Teladoc Health’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TDOC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 8, 2025 (DEF 14A).

Free

Get Jason Gorevic’s full pay file as a PDF — free

More than this page: up to 10 years of Jason’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jason Gorevic compensation by year

Teladoc Health Summary Compensation Table · all 9 fiscal years held
In US dollars, as Teladoc Health reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Salary$500,000$500,000$511,250$515,000$544,167$654,167$695,833$764,167$211,318
Bonus$0$0$0$0$0$0$0$0$0
Stock awards$0$1,525,000$3,071,818$6,799,988$6,800,017$10,000,131$10,000,020$10,000,006$5,943,704
Option awards$2,668,669$4,293,406$3,080,863$0$0$0$0$0$0
Non-equity incentive$400,000$750,000$643,750$669,500$1,100,000$972,000$168,000$836,363$108,690
Pension and deferred compensation$0$0$0$0$0$0$0$0$0
All other$37,902$36,036$21,641$11,200$11,400$11,600$12,200$13,200$3,102,564
Total$3,606,571$7,104,442$7,329,322$7,995,688$8,455,584$11,637,898$10,876,053$11,613,736$9,366,276

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Teladoc Health, Inc. DEF 14A filed April 8, 2025, accession 0001477449-25-000040, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Teladoc Health, Inc. filed document, accession 0001477449-25-000040. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2025.

$3.6M
$7.1M
$7.3M
$8.0M
$8.5M
$11.6M
$10.9M
$11.6M
$9.4M
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU49,603$450,891—
RSU32,954$299,552—
RSU6,738$61,248—

Per the Outstanding Equity Awards at Fiscal Year-End table in Teladoc Health, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Change-in-control & termination

estimated payments Teladoc Health discloses, by trigger · FY2022
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$1,218,000$1,989,320$43,101$3,250,803
Change in control and involuntary termination$2,478,000$3,677,244$43,101$6,198,727
Change in control, no termination—$706,284—$706,284

Per the Potential Payments Upon Termination or Change in Control table in Teladoc Health, Inc.'s FY2022 proxy. Estimates as the company printed them; a dash means it printed no figure.

Teladoc Health’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Charles Divita, IIIChief Executive Officer$16,061,267
Jason Gorevic · this pageFormer Chief Executive Officer$9,366,276
Mala MurthyChief Financial Officer$5,230,694
Michael WatersFormer Chief Operating Officer$4,217,861
Laizer KornwasserFormer President, Enterprise Growth and Global Markets$3,969,547
Carlos NuenoPresident, International$2,739,138
Adam C. VandervoortChief Legal Officer and Secretary$2,634,319
Kelly BlissPresident, U.S. Group Health$2,514,739

Board service

Teladoc Health board · FY2022–FY2023

How this board is paid

Company policy: Teladoc Health pays directors a $45,000 cash retainer and $225,000 in RSUs. As stated in Teladoc Health's FY2023 proxy.

The full Teladoc Health compensation record

free company brief

This page is one person within Teladoc Health's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Teladoc Health proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Teladoc Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jason Gorevic's compensation dossier · One-time report. No refunds.